HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical evaluation of 201TI single photon emission computed tomography in patients with large opacities due to silicosis with bronchogenic carcinoma].

Abstract
201T1 single photon emission computed tomography (201T1 SPECT) was used to evaluate 18 patients with large opacities due to silicosis and 22 others with bronchogenic carcinoma. An early scan and a delayed scan were obtained and the retention index was calculated from the early ratio and the delayed ratio. In patients with silicosis, the retention index and the two ratios were significantly lower than in the patients with bronchogenic carcinoma (p < 0.01). In patients with stable shadows on chest X-ray films due to large opacities of silicosis, the delayed ratio was the same as or lower than the early ratio. However, in patients with silicosis who had high activity in large opacities, the delayed ratio was higher than the early ratio. These results suggest that 201)T1 SPECT is useful for evaluating the activity of large opacities in patients with silicosis and for differentiating large opacities caused by silicosis from those caused by bronchogenic carcinoma.
AuthorsK Sunami, T Kishimoto, T Yonei, S Ozaki, K Kimura, H Fujioka, M Ohke, T Ohnoshi
JournalNihon Kyobu Shikkan Gakkai zasshi (Nihon Kyobu Shikkan Gakkai Zasshi) Vol. 34 Issue 6 Pg. 659-64 (Jun 1996) ISSN: 0301-1542 [Print] Japan
PMID8741531 (Publication Type: Journal Article)
Chemical References
  • Thallium Radioisotopes
  • thallium chloride
  • Thallium
Topics
  • Aged
  • Carcinoma, Bronchogenic (diagnostic imaging)
  • Diagnosis, Differential
  • Female
  • Humans
  • Lung Neoplasms (diagnostic imaging)
  • Male
  • Middle Aged
  • Radiography, Thoracic
  • Silicosis (diagnostic imaging)
  • Thallium
  • Thallium Radioisotopes
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: